ArticleJournal of clinical medicine2025

The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload.

Manatchaya Pongamnuaykrit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.